Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
For my Russian readers, I am in Listvjanka today & tomorrow; Irkutsk Friday and Saturday. It would be nice to meet any of you. I think my phone number is +7 911 816 6339
DALLAS--(BUSINESS WIRE)--Researchers at the University of Pennsylvania recently released the results of a study showing that the cancer ...
Prostate cancer is the second most common cancer in men, with almost one ... It is a curable cancer that can range from slow-growing tumors (more ... based on immunotherapy called checkpoint inhibitors, which are drugs able to ...
There are now an increasing number of immunotherapy agents available ... one each in lung cancer (nivolumab) and prostate cancer (sipuleucel-T).
A drug approved to treat skin cancer has produced what researchers are ... there are guidelines to help enhance your body's own immune system.
The drug belongs to checkpoint inhibitor that is a promising class of agents which unleash an immune system attack against cancer. This methodology ...
Kidney failure, cancer, the weakening of immune system and fetal deaths after 20 weeks of pregnancy are among the latest threats being posed by the ...
Breastfeeding has been shown to improve a baby's immune system, lower the ... The study, published in the Journal of the National Cancer Institute, ...
Use of Post-Op RT Waning in Prostate Cancer
Radiation therapy for recurrence-prone radical prostatectomy is on the decline in the U.S., despite strong evidence and supporting guidelines, according to an analysis of a national database. FULL STORY»
Tumor Genomics: Sequence Normal Tissue, Too
The standard approach of analyzing malignant tumors for unique genetic mutations to target therapy may not be sufficient and may, in fact, lead to inappropriate treatment, researchers said. FULL STORY»
Radiation therapy for recurrence-prone radical prostatectomy is on the decline in the U.S., despite strong evidence and supporting guidelines, according to an analysis of a national database. FULL STORY»
Tumor Genomics: Sequence Normal Tissue, Too
The standard approach of analyzing malignant tumors for unique genetic mutations to target therapy may not be sufficient and may, in fact, lead to inappropriate treatment, researchers said. FULL STORY»
Your Houston News |
One serving per day reduces breast cancer risk by over 50 percent. And one or more servings of cabbage = per week reduce pancreatic cancer by 38 ...
Cyclopamine-loaded Core-crosslinked Polymeric Micelles Enhance Radiation Response in Pancreatic Cancer and Pancreatic Stellate Cells.
Matthews was diagnosed with pancreatic cancer on Mother's Day last year, he said in an interview. He had surgery in the fall to remove 40 percent of ...
... melanoma, colorectal, oesophageal, pancreatic, hepatobiliary, prostate and renal cell cancers. ... The study appeared in the journal Cancer.
... using the antibody for the treatment of mesothelin-expressing cancers, including mesothelioma, lung cancer, ovarian cancer and pancreatic cancer.
Science Daily Cancer News
While black and white men under age 65 diagnosed with early-stage breast cancer received similar treatment, blacks had a 76 percent higher risk of death than whites, research shows. Male breast cancer is a rare disease, accounting for less than 1% of all cancers in men and approximately 2% of all breast cancers in the United States. Black men have a higher incidence of breast cancer and are more likely to be diagnosed with breast cancer at a younger age than their white counterparts.
Scientists have developed a significantly better computer tool for finding genetic alterations that play an important role in many cancers but were difficult to identify with whole-genome sequencing. The tool is an algorithm called CONSERTING, short for Copy Number Segmentation by Regression Tree in Next Generation Sequencing.
A recent study compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of prostate-specific membrane antigen in patients with biochemical recurrence after radical prostatectomy. It is especially noteworthy that this hybrid PSMA-ligand identified a large number of positive findings in the clinically important range of low PSA-values.
Kinesiology research offers encouraging information for cancer patients: A brisk walk or a slow jog on a regular basis may be the key to improved cancer treatments. Research also has shown that moderate exercise can help cancer patients counteract some of the side effects of treatment -- such as low blood count, fatigue, cachexia and lost muscle mass -- which has led to many researchers labeling this as "aerobic exercise therapy" for patients with cancer.
Scientists have identified a mechanism that helps leukemia cells resist glucocorticoids, a finding that lays the foundation for more effective treatment of cancer and possibly a host of autoimmune diseases. The research focused on glucocorticoids, a class of steroid hormones.
Using brain tumor samples collected from children in the United States and Europe, an international team of scientists found that the drug panobinostat and similar gene regulating drugs may be effective at treating diffuse intrinsic pontine gliomas, an aggressive and lethal form of pediatric cancer.
Tambahkan Komentar